Literature DB >> 21544605

On the meaningfulness of testing preference axioms in stated preference discrete choice experiments.

Jens Leth Hougaard1, Tue Tjur, Lars Peter Osterdal.   

Abstract

A stream of studies on evaluation of health care services and public goods have developed tests of the preference axioms of completeness and transitivity and methods for detecting other preference phenomena such as unstability, learning- and tiredness effects, and random error, in stated preference discrete choice experiments. This methodological paper tries to identify the role of the preference axioms and other preference phenomena in the context of such experiments and discusses whether or how such axioms and phenomena can be subject to meaningful (statistical) tests.

Entities:  

Mesh:

Year:  2011        PMID: 21544605     DOI: 10.1007/s10198-011-0312-4

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  6 in total

1.  Complete preferences over health states: a reply to the paper by Shiell et al.

Authors:  A Oliver
Journal:  Health Econ       Date:  2000-12       Impact factor: 3.046

2.  Will our understanding of completeness ever be complete?

Authors:  A Shiell; P Hawe; J Seymour
Journal:  Health Econ       Date:  2000-12       Impact factor: 3.046

3.  Are preferences over health states complete?

Authors:  A Shiell; J Seymour; P Hawe; S Cameron
Journal:  Health Econ       Date:  2000-01       Impact factor: 3.046

4.  Revisiting the axiom of completeness in health care.

Authors:  Mandy Ryan; Fernando San Miguel
Journal:  Health Econ       Date:  2003-04       Impact factor: 3.046

5.  Deleting 'irrational' responses from discrete choice experiments: a case of investigating or imposing preferences?

Authors:  Emily Lancsar; Jordan Louviere
Journal:  Health Econ       Date:  2006-08       Impact factor: 3.046

6.  Methodological issues in the application of conjoint analysis in health care.

Authors:  M Ryan; E McIntosh; P Shackley
Journal:  Health Econ       Date:  1998-06       Impact factor: 3.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.